A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT00960531 · TERMINATED
Trial details
- NCT number
- NCT00960531
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2013-12-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.